Plasma extractions were analyzed on C18 or Scherzo columns coupled to QTOF via positive and negative ESI. Therefore, each sample was analyzed in four LC-MS modes: (i) reversed-phase C18 UPLC in positive and negative ESI and, (ii) mixed reversed-phase/ion-exchange Scherzo HPLC in positive and negative ESI. Buffer extractions were analyzed on Orbitrap Velos TM mass spectrometer in positive ESI.
LC-MS mixed-mode method for the analysis of extractions in plasma
The stationary phase of Scherzo SM-C18 HPLC column is composed of C18 alkyl and weak cation and anion moieties. Therefore, solvent was supplemented with ammonium acetate buffer to execute mixed mode (reversed-phase/ion exchange) chromatography and elute ionic species from the column. The binary solvent system consisted of 2 mM ammonium acetate buffer, pH 3.5 in 2% acetonitrile and 98% of water (solvent A) and 100 mM ammonium acetate buffer, pH 3.5 in 96% acetonitrile and 4% of water (solvent B). The samples were separated at 0.22 mL/min flow rate at 35°C using the following gradient: 0 % B for the first 2 min, increase of B from 0 to 20% between 2 nd and 10 th min, increase of B from 20 to 100% between 10 th and 25 th min, isocratic hold at 100% B for 6 min and 6 min of re-equilibration to 100% A. In positive ESI, the capillary voltage was kept at 3500 V for the entire run, while nozzle voltage was set to 200 V for the first 5 minutes of run and to 800 V between 5 th and 35 th minutes. In negative ESI, nozzle and capillary voltages were held at 250 V and 3750 V for the entire run. All other MS settings were the same as described for LC-MS RP in previous section. For targeted analysis, all samples were analyzed in random order with QC samples (mixture of all analyzed samples (iii) loaded at each 11 th injection. XICs were extracted with 15 ppm accuracy and aligned within ± 0.15 minutes retention time interval. Metabolite identity was confirmed by the match of retention time and m/z between signals in analyzed samples and signals in calibration points. The concentrations of standard analytes were quantitated using external calibration curves obtained as described in materials and methods. For both targeted and global analyses, at least 10 runs of QC samples preceded batch runs in order to stabilize chromatography and ESI performance. For the global analysis, to ensure confident comparisons across extraction methods in global metabolomics analysis, samples from solvent, LLE and SPE extractions were analyzed side by side in 6 randomly organized sub-batches containing a single replicate from each of 7 extractions and one QC
sample. In order to analyze seven blank samples (type i) from seven methods in six sub-batches, five of sub-batches comprised one and the sixth sub-batch -two blank samples. PCA was performed using SIMCA 14 (Umetrics, Sweden) on all high-quality data described in Methods section, after Pareto scaling. PCA was used to verify the stability of LC-MS signals throughout the analysis by checking the clustering of QC signals for each analytical batch (Supplementary Figure 3) . It can also be used to visualize repeatability and similarity between different extraction methods.
LC-MS mixed-mode method for the analysis of extractions in buffer
The column and buffer composition were identical to the analysis in plasma. Samples were separated at 0.22 mL/min flow rate at 35 ⁰C using the following gradient: 0 % B for the first 2 min, increase of B from 0 to 100% between 2 nd and 18 th min, isocratic hold at 100% B for 6 min and 7 min of re-equilibration to 100 % A. Column was coupled to Orbitrap Velos TM mass spectrometer in positive ESI, at the following settings: ESI voltage 3.25 kV, heater and capillary temperature at 350 ⁰C, sheet gas, auxillary gas and sweep gas flow rates at 40, 10 and 0 arbitrary units, respectively; detection of signals was executed in the range 50-1000 m/z at 250 ms activation time, normalized collision energy 35 V, resolution 60,000 and mass accuracy 10 ppm. Deconvolution of raw data and quantitative analysis was executed using Xcalibur TM , v. 2.0 (Thermo Fisher Scientific, Waltham, MA, USA) and statistical analysis in Microsoft Excel unless otherwise specified.
Supplementary Figure 1.
Study design for the targeted and global metabolomics analysis of extraction methods. Blue and purple colors designate experiments in buffer and blood plasma, respectively. Green color designates LC-MS analyses step executed on RP (reversed phase) and mixed mode (weak anion/weak cation/RP) mode columns. Peach color designates major data analysis blocks. Supplementary Table 3. Recovery and precision of extraction of standard analytes from plasma. The table displays average recovery calculated from individual replicates after subtraction of any endogenous level of metabolite present (n=6, amount of standard analyte spiked before extraction = 100%) and a relative standard deviation (standard deviation/mean*100%, n=6) of recovered amounts. LogP was obtained online from ChemSpider website (http://www.chemspider.com/Default.aspx) and represents predicted octanol-water partition coefficients (predicted ACD/LogP, ACD/Labs, Toronto, Canada). "ND" stands for "not detected", "N/A" stands for "not applicable". For details on the usage and fate of analytes see Supplementary Table 8 .
Supplementary Figure 2 Ionization effects observed in human plasma in all LC-MS analysis across all analytes and extraction methods.
On Y axis, graph displays area ratios between analytes of the same concentrations in buffer and a matrix calibration points ((area in spiked matrix-area in blank matrix) / (area in buffer-area in blank)*100%)) assuming the area of analyte in the buffer as 100 %. Analytes are displayed along X-axis from left to right according to the increase of their predicted ACD/LogP, ACD Laboratories Toronto, Canada). Legend designating extraction methods on RP positive panel is same for all panels. Error bars represent relative standard deviation of matrix effects between different concentration levels tested. Due to very high matrix effect of some analytes in RP and Scherzo in positive ESI, full scale inserts were placed. Missing bars indicate that matrix effects could not be calculated due to one of three possible events: (i) analyte is not detected in buffer, (ii) analyte is not detected in a particular matrix or (iii) analyte signal was saturated (signal did not increase together with increased concentration at the concentration levels tested). The differences in matrix effect between 4-aminobutanoic acid and its deuterated analog in RP positive ESI (NDM) and Scherzo in positive ESI (methanol) is most likely due to the strong suppressing matrix effect. The differences in matrix effects between cholic acid, thyroxine and their deuterated analogs in RP in negative ESI are most likely due to the error in preparation of calibration points in the correspondent samples where it was not detected. Cortisol (d4) was removed from the graph because it was not detected in neither analysis except RP in positive ESI. See supplementary Table 4 Efficiency of extraction methods in buffer and plasma for metabolite standards using the data obtained in RP analysis in positive or negative ESI mode. The first two columns compare the extraction methods using the number of analytes recovered in extractions from buffer and plasma at different thresholds of precision and recovery (R). The number of analytes recovered with RSD less than 20% and R≥80% and can be considered as metabolites where the extraction method provides excellent performance. The metabolites which have RSD less than 30%, and recovery higher than 50% can be considered as metabolites with acceptable performance in semi-quantitative methods such as global metabolomics. The table also shows mean recovery and repeatability (expressed as mean RSD) across all metabolites observed in a given extraction method. The total number of standard analytes detected from standard mixture by at least one extraction method is 22 metabolites for buffer and 24 metabolites for plasma extractions. Supplementary Table 8 summarizes which metabolites were detected/analyzed in only one matrix. *Higher mean recovery of PEP2 is caused by the larger number of analytes with enhanced matrix effect ( Table 7 Summary of matrix effects observed for all metabolites across all extraction methods and LC-MS analyses. Not all analytes were successfully detected in buffer (NDB) or in an extract (NDM) which made the calculation of matrix effect impossible as specified. Analytes which did not respond to increased concentrations of spiked standards or which exhibited negative signal response were considered to be suppressed or saturated (SS) and were not used for calculation of matrix effects.
